FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charalambos Economides

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Magnetic Resonance Imaging

Anatomy

Phenomena

False Negative Reactions

Co-author Network

Publications

TOP 3
Annita Kolnagou; Dilek Yazman; Charalambos Economides; Eleni Eracleous; George J Kontoghiorghes
Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
Annita Kolnagou; Charalambos Economides; Eleni Eracleous; George J Kontoghiorghes
Long term comparative studies in thalassemia patients treated with deferoxamine or a deferoxamine/deferiprone combination. Identification of effective chelation therapy protocols.
Annita Kolnagou; Charalambos Economides; Eleni Eracleous; George J Kontoghiorghes
Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charalambos Economides (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Annita Kolnagou; Dilek Yazman; Charalambos Economides; Eleni Eracleous; George J Kontoghiorghes
Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
Hemoglobin 2009;33(5):312-22.
2008: Annita Kolnagou; Charalambos Economides; Eleni Eracleous; George J Kontoghiorghes
Long term comparative studies in thalassemia patients treated with deferoxamine or a deferoxamine/deferiprone combination. Identification of effective chelation therapy protocols.
Hemoglobin 2008;32(1-2):41-7.
2006: Annita Kolnagou; Charalambos Economides; Eleni Eracleous; George J Kontoghiorghes
Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*.
Hemoglobin 2006;30(2):219-27.
2005: George J Kontoghiorghes; Eleni Eracleous; Charalambos Economides; Annita Kolnagou
Advances in iron overload therapies. prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations.
Current medicinal chemistry 2005;12(23):2663-81.
2004: Annita Kolnagou; Charis Fessas; Antonis Papatryphonas; Charalambos Economides; George J Kontoghiorghes
Prophylactic use of deferiprone (L1) and magnetic resonance imaging T2* or T2 for preventing heart disease in thalassaemia.
British journal of haematology 2004;127(3):360-1; author reply 361-2.